News Results
There are 990,143 News Results
Oct 15, 2019
SAN JOSE, Calif., Oct. 15, 2019 /PRNewswire/ -- Today at Zoomtopia 2019, Poly ("Poly" - formerly Plantronics and Polycom), unveiled a full range of video endpoints that dramatically simplify the...
Oct 17, 2019
NEW YORK, Oct. 17, 2019 /PRNewswire/ -- LivePerson, Inc. (Nasdaq: LPSN), a global leader in conversational commerce solutions, today announced the findings of its
Oct 30, 2019
FALLS CHURCH, Va., Oct. 30, 2019 /PRNewswire/ -- GTL , a leader in transformative corrections technology that improves outcomes for inmates and facilities, today announced that it is entering its...
Oct 30, 2019
PALO ALTO, Calif., Oct. 30, 2019 /PRNewswire/ -- Icon Group, Australia's largest dedicated provider of cancer care, with a growing reach into New Zealand and Asia, has made a purchase...
Nov 13, 2019
TAMPA, Fla., Nov. 13, 2019 /PRNewswire/ -- Black Book(TM) surveyed 1,640 providers of long-term and post-acute care (nursing homes, hospitals, short-term rehabilitation facilities, home health services, durable medical equipment/DME distributors,...
Dec 4, 2019
KANAZAWA, Japan, Dec. 4, 2019 /PRNewswire/ --
Dec 16, 2019
DETROIT, Dec. 16, 2019 /PRNewswire/ -- The North American International Auto Show (NAIAS) today announced Charity Preview will expand into Hart Plaza with two ticket options offering indoor and outdoor...
Dec 27, 2019
PHILADELPHIA, Dec. 27, 2019 /PRNewswire/ -- In the largest-ever study to measure the impact of population health strategies and tools on hospital outcomes among Medicaid-enrolled children, a team at Children's...
Jan 14, 2020
XOSPATA is the first and only targeted treatment approved by Health Canada for patients with relapsed or refractory Acute Myeloid Leukemia with a FLT3 mutation. The approval of XOSPATA marks...
Jan 14, 2020
NORTH CHICAGO, Ill., Jan. 14, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced that SKYRIZI(TM) met both primary and all ranked secondary endpoints, including superiority...